Sudarshan Pharma Industries share news, announcements and annual reports
NSE: SUDARSHANBSE: 543828Chemicals & PetrochemicalsSmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹37.48.
30 Oct: open ₹39.04, high ₹39.29, low ₹34.70
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹927 Cr1,697th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 31.93
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.74
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 10.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 1.99
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,84,31446.6% delivered
Sudarshan Pharma Industries share news and announcements
248 announcements, routine notices left out, newest first. Page 5 of 5.
Nov 2023
10 Nov · Regulation 33 Of SEBI (Listing Obligations & Disclosure Requirements), 2015.
3 Nov · Board meeting
Meeting on 10 Nov 2023: employees stock option plan and half yearly results
Oct 2023
20 Oct · Complaince Certificate Pursuant To Regulation 7(3) Of SEBI (Listing Obligation & Disclosure Requirement)
7 Oct · Business Update Of Sudarshan Pharma Industries Limited At Https://Youtu.Be/-Sr3focqrka?Si=Bqawpoxwgye36rdn
Sep 2023
Aug 2023
24 Aug · Intimation For Incorporation Of A Subsidiary Company & Outcome Of The Meeting Of Board Of Directors Of The Company Held On August 18, 2023.
18 Aug · Intimation For Incorporation Of A Subsidiary Company & Outcome Of The Meeting Of Board Of Directors Of The Company Held On August 18, 2023.
14 Aug · Board meeting
Meeting on 18 Aug 202310 Aug · Announcement under Regulation 30 (LODR)-Meeting Updates
9 Aug · Business Update Of Sudarshan Pharma Industries Limited.
1 Aug · Business Update Of Sudarshan Pharma Industries Limited.
Jul 2023
27 Jul · Board meeting
Meeting on 2 Aug 202326 Jul · Confirmation Of Successfully Completion Of First Milestone In Development (R&D) & Manufacturing Sample Of Vitamin B6 (PYRIDOXINE HYDROCHLORIDE)' Finish API.
26 Jul · Approval Of Application Under The Production Linked Incentive (PLI) Scheme.
21 Jul · Outcome Of The Meeting Of Board Of Directors Of The Company Held On July 21, 2023
14 Jul · Board meeting
Meeting on 21 Jul 2023: employees stock option plan, final dividend and increase in authorised capital
Jun 2023
May 2023
31 May · Statement Of Variation For Proceeds Of Public Issue Pursuant To Reg. 32 Of SEBI (LODR) Regulations, 2015.
26 May · Intimation Regarding Statement Of Variation Pursuant To Reg. 32(1)(B) Of SEBI(LODR)Regulations, 2015
26 May · Outcome Of The Meeting Of Board Of Directors Of The Company Held On May 26, 2023.
26 May · Outcome Of The Meeting Of Board Of Directors Of The Company Held On May 26, 2023.
23 May · Board meeting
Meeting on 26 May 2023: audited results and final dividend
Apr 2023
28 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
28 Apr · Compliance Certificate Pursuant To Reg. 7(3) Of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015
28 Apr · Certificate Pursuant To Reg. 40(9) & 40(10) Of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015
Mar 2023
22 Mar · Listing of equity shares of Sudarshan Pharma Industries Ltd
Trading Members of the Exchange are hereby informed that effective from March 22, 2023, the equity shares of Sudarshan Pharma Industries Ltd (Scrip Code: 543828) are listed and admitted ....